Coherus BioSciences, Inc. Contracts & Agreements

Exclusive License and Distribution Agreement dated as of June 27, 2024 between Coherus BioSciences, Inc. and Apotex, Inc (Filed With SEC on August 8, 2024)

Omnibus Amendment to Transaction Documents dated as of June 25, 2024 among Coherus BioSciences, Inc., Coduet Royalty Holdings, LLC and Ankura Trust Company, LLC (Filed With SEC on August 8, 2024)

Amended and Restated 2014 Equity Incentive Award Plan (Filed With SEC on August 8, 2024)

Asset Purchase Agreement, by and between Coherus BioSciences, Inc. and Hong Kong King-Friend Industrial Company Ltd., dated as of June 26, 2024 (Filed With SEC on June 27, 2024)

Amendment No. 2 to the Exclusive License and Commercialization Agreement, as amended, as of March 13, 2024, by and between Coherus BioSciences, Inc. and Shanghai Junshi... (Filed With SEC on May 9, 2024)

Exclusive Product License Agreement, dated March 23, 2021, by and between Vaccinex, Inc. and Surface Oncology, Inc (Filed With SEC on March 15, 2024)

Consent, Partial Release and Third Amendment to Loan Agreement dated as of February 5, 2024 among Coherus BioSciences, Inc., Biopharma Credit PLC, BPCR Limited Partnership and... (Filed With SEC on February 5, 2024)

Purchase and Sale Agreement, by and between Coherus BioSciences, Inc. and Sandoz Inc., dated January 19, 2024 (Filed With SEC on January 22, 2024)

Settlement and License Agreement among Coherus BioSciences, Inc., AbbVie Inc. and AbbVie Biotechnology Ltd dated January 24, 2019 (Filed With SEC on November 6, 2023)

Amendment No. 2 to Sales Agreement between Coherus BioSciences, Inc. and Cowen and Company, LLC dated September 11, 2023 (Filed With SEC on November 6, 2023)

Amendment No. 1 to Sales Agreement between Coherus BioSciences, Inc. and Cowen and Company, LLC, dated May 15, 2023 (Filed With SEC on August 2, 2023)

Agreement and Plan of Merger, by and among Coherus BioSciences, Inc., Crimson Merger Sub I, Inc., Crimson Merger Sub II, LLC and Surface Oncology, Inc., dated June 15, 2023 (Form... (Filed With SEC on June 16, 2023)

Underwriting Agreement, dated as of May 16, 2023, among Coherus BioSciences, Inc. and J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as representatives of the... (Filed With SEC on May 18, 2023)

Second Amendment and Waiver to Loan Agreement dated as of February 6, 2023, among Coherus BioSciences, Inc., the Collateral Agent and the Lenders party thereto (Filed With SEC on May 8, 2023)

Executive Change in Control and Severance Plan, effective January 1, 2023 (Filed With SEC on May 8, 2023)

Letter Agreement between Coherus BioSciences, Inc. and Vladimir Vexler, dated as of March 27, 2023 (Filed With SEC on May 8, 2023)

License Agreement, dated June 22, 2022, among Coherus BioSciences, Inc., Bioeq AG and Genentech Inc (Filed With SEC on March 6, 2023)

First Amendment to Loan Agreement dated as of April 7, 2022 among Coherus BioSciences, Inc., the Collateral Agent and the Lenders party thereto (Filed With SEC on August 4, 2022)

Letter Agreement, dated January 9, 2022, between Coherus BioSciences, Inc. and Shanghai Junshi Biosciences, Co., Ltd (Filed With SEC on February 23, 2022)

Loan Agreement dated as of January 5, 2022 among the Company, the Guarantors, the Collateral Agent and the Lenders party thereto (Filed With SEC on January 7, 2022)

Separation Agreement, dated as of August 23, 2019, by and between Coherus BioSciences, Inc. and Darlene Horton (Filed With SEC on May 7, 2020)

Form of Confirmation of Base Call Option Transaction (Filed With SEC on April 17, 2020)

Indenture, dated as of April 17, 2020, between Coherus BioSciences, Inc. and U.S. Bank National Association, as trustee (Filed With SEC on April 17, 2020)

First Amendment to Credit Agreement, dated as of April 13, 2020, by and between Coherus BioSciences, Inc. and affiliates of Healthcare Royalty Partners (Filed With SEC on April 14, 2020)

Second Amendment to Convertible Note Purchase Agreement, dated as of April 13, 2020, among Coherus BioSciences, Inc., the Guarantors party thereto, HealthCare Royalty Partners... (Filed With SEC on April 14, 2020)

License Agreement, dated January 13, 2020, by and between Coherus BioSciences, Inc. and Innovent Biologics (Suzhou) Co., Ltd (Filed With SEC on February 27, 2020)

License Agreement, dated November 4, 2019, by and between Coherus BioSciences, Inc. and Bioeq IP AG (Filed With SEC on February 27, 2020)

Description of Coherus Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2020)

Third Amendment, effective May 24, 2019, by and between Hudson 333 Twin Dolphin Plaza, LLC and Coherus BioSciences, Inc (Filed With SEC on November 8, 2019)

Fourth Amendment, effective September 4, 2019, by and between Hudson 333 Twin Dolphin Plaza, LLC and Coherus BioSciences, Inc (Filed With SEC on November 8, 2019)

Confidential Litigation Settlement Agreement and Release, dated as of April 30, 2019 between Amgen Inc. and Amgen USA Inc. (collectively Amgen), and Coherus BioSciences Inc (Filed With SEC on August 5, 2019)

Credit Agreement, dated as of January 7, 2019, by and among the Company and the Lenders (Filed With SEC on January 11, 2019)

Underwriting Agreement, dated May 22, 2018, among Coherus BioSciences, Inc., J.P. Morgan Securities LLC and Citigroup Global Markets Inc (Filed With SEC on May 25, 2018)

Registration Rights Agreement, dated as of November 30, 2017, by and between the Company and KBI Biopharma, Inc (Filed With SEC on December 5, 2017)

Stock Purchase Agreement, dated as of November 30, 2017, by and between the Company and KBI Biopharma, Inc (Filed With SEC on December 5, 2017)

Letter Agreement to Master Service Agreement, dated as of September 6, 2017, by and between Medpace, Inc. and Coherus BioSciences, Inc (Filed With SEC on November 6, 2017)

COHERUS BIOSCIENCES, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 22, 2017)

COHERUS BIOSCIENCES, INC. STOCK PURCHASE AGREEMENT (Filed With SEC on August 22, 2017)

COHERUS BIOSCIENCES, INC. 5,154,640 Shares of Common Stock Underwriting Agreement (Filed With SEC on February 13, 2017)

COHERUS BIOSCIENCES, INC. $100,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on October 28, 2016)

SECOND AMENDMENT (Filed With SEC on September 26, 2016)

COHERUS BIOSCIENCES, INC. 2016 EMPLOYMENT COMMENCEMENT INCENTIVE PLAN RESTRICTED STOCK AWARD GRANT NOTICE (Filed With SEC on August 9, 2016)

Coherus BioSciences, inc. 2016 Employment commencement incentive PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE (Filed With SEC on August 9, 2016)

COHERUS BIOSCIENCES, INC. 2016 EMPLOYMENT COMMENCEMENT INCENTIVE PLAN ARTICLE 1. PURPOSE (Filed With SEC on August 9, 2016)

COHERUS BIOSCIENCES, INC. 2016 EMPLOYMENT COMMENCEMENT INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on August 9, 2016)

COHERUS BIOSCIENCES, INC. 3,500,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on May 26, 2016)

Amendment Dated as of March 25, 2016 to Senior Convertible Note Purchase Agreement (Filed With SEC on May 9, 2016)

COHERUS BIOSCIENCES, INC., asIssuer, the Guarantors from time to time party hereto, as Guarantors AND HealthCare Royalty Partners III, L.P., MX II Associates LLC, KMG... (Filed With SEC on February 29, 2016)

COHERUS BIOSCIENCES, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 14, 2015)

COHERUS BIOSCIENCES, INC. STOCK PURCHASE AGREEMENT (Filed With SEC on September 14, 2015)

AMENDED AND RESTATED LICENSE AGREEMENT by and among COHERUS BIOSCIENCES, INC., BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE CORPORATION, AND BAXTER HEALTHCARE SA dated April 10,... (Filed With SEC on May 11, 2015)

MASTER SERVICES AGREEMENT (Filed With SEC on May 11, 2015)

COHERUS BIOSCIENCES, INC. [] Shares of Common Stock Underwriting Agreement (Filed With SEC on March 30, 2015)

FIFTH AMENDMENT (Filed With SEC on December 11, 2014)

COHERUS BIOSCIENCES, INC. 2014 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK AWARD GRANT NOTICE (Filed With SEC on November 4, 2014)

COHERUS BIOSCIENCES, INC. 2014 EQUITY INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on November 4, 2014)

COHERUS BIOSCIENCES, INC. 2014 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE (Filed With SEC on November 4, 2014)

COHERUS BIOSCIENCES, INC. 2014 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on October 24, 2014)

COHERUS BIOSCIENCES, INC. [ ] Shares of Common Stock Underwriting Agreement (Filed With SEC on October 24, 2014)

INDEMNIFICATION AGREEMENT (Filed With SEC on October 24, 2014)

COHERUS BIOSCIENCES, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE,SCOPE AND ADMINISTRATION OF THE PLAN (Filed With SEC on October 24, 2014)

CONFIDENTIAL (Filed With SEC on October 24, 2014)

LICENSE AGREEMENT by and between BIOGENERICS, INC. and DAIICHI SANKYO COMPANY,LIMITED dated January 23rd, 2012 TABLE OF CONTENTS (Filed With SEC on October 20, 2014)

LICENSE AGREEMENT by and among COHERUS BIOSCIENCES, INC., BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE CORPORATION, AND BAXTERHEALTHCARE SA dated August 30, 2013 TABLE OF CONTENTS (Filed With SEC on October 20, 2014)

AGREEMENTAND PLAN OF MERGER BY AND AMONG COHERUS BIOSCIENCES, INC., COHERUS INTERMEDIATE CORP., COHERUS ACQUISITION CORP., INTEKRIN THERAPEUTICS INC., AND FORTIS ADVISORS LLC... (Filed With SEC on September 25, 2014)

COHERUS BIOSCIENCES, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on September 25, 2014)

LICENSE AGREEMENT by and between BIOGENERICS, INC. and DAIICHI SANKYO COMPANY,LIMITED dated January 23rd, 2012 TABLE OF CONTENTS (Filed With SEC on September 25, 2014)

LICENSE AGREEMENT by and among COHERUS BIOSCIENCES, INC., BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE CORPORATION, AND BAXTERHEALTHCARE SA dated August 30, 2013 TABLE OF CONTENTS (Filed With SEC on September 25, 2014)

FIRST AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on September 25, 2014)

DISTRIBUTION AGREEMENT (Filed With SEC on September 25, 2014)

CONFIDENTIAL NON-EXCLUSIVE LICENSE AGREEMENT [Cabilly Patents] (Filed With SEC on September 25, 2014)

CONFIDENTIAL (Filed With SEC on September 25, 2014)

/s/ DouglasFarrar (Filed With SEC on September 25, 2014)

Office Lease THE TOWERS @SHORES CENTER 201 REDWOOD SHORES REDWOOD CITY, CALIFORNIA Between CA-TOWERS AT SHORESCENTER LIMITED PARTNERSHIP, a Delaware limited partnership as... (Filed With SEC on September 25, 2014)

FIRST AMENDMENT (Filed With SEC on September 25, 2014)

SECOND AMENDMENT (Filed With SEC on September 25, 2014)

THIRD AMENDMENT (Filed With SEC on September 25, 2014)

FOURTH AMENDMENT (Filed With SEC on September 25, 2014)

AIR COMMERCIAL REAL ESTATE ASSOCIATION STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE GROSS (Filed With SEC on September 25, 2014)

FIRST AMENDMENT TO LEASE (Filed With SEC on September 25, 2014)

BIOGENERICS, INC. 2010EQUITY INCENTIVE PLAN (Filed With SEC on September 25, 2014)

COHERUS BIOSCIENCES INC. 2010 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on September 25, 2014)

CONFIDENTIAL (Filed With SEC on September 25, 2014)

Category

Industry

Companies

Contracts

Coherus BioSciences, Inc. Contracts & Agreements